307 related articles for article (PubMed ID: 18338653)
1. Hormonal contraceptives for acne management.
Rich P
Cutis; 2008 Jan; 81(1 Suppl):13-8. PubMed ID: 18338653
[TBL] [Abstract][Full Text] [Related]
2. New developments in hormonal therapy for acne.
Tan JK
Skin Therapy Lett; 2007 Sep; 12(7):1-3. PubMed ID: 17940710
[TBL] [Abstract][Full Text] [Related]
3. Superiority of a combined contraceptive containing drospirenone to a triphasic preparation containing norgestimate in acne treatment.
Thorneycroft lH; Gollnick H; Schellschmidt I
Cutis; 2004 Aug; 74(2):123-30. PubMed ID: 15379365
[TBL] [Abstract][Full Text] [Related]
4. Drospirenone: a novel progestin.
Rapkin AJ; Winer SA
Expert Opin Pharmacother; 2007 May; 8(7):989-99. PubMed ID: 17472544
[TBL] [Abstract][Full Text] [Related]
5. Oral contraceptives in the treatment of acne.
Tan JK; Degreef H
Skin Therapy Lett; 2001 Feb; 6(5):1-3. PubMed ID: 11242137
[TBL] [Abstract][Full Text] [Related]
6. Drospirenone/ethinylestradiol 3mg/20microg (24/4 day regimen): a review of its use in contraception, premenstrual dysphoric disorder and moderate acne vulgaris.
Fenton C; Wellington K; Moen MD; Robinson DM
Drugs; 2007; 67(12):1749-65. PubMed ID: 17683173
[TBL] [Abstract][Full Text] [Related]
7. Update and future of hormonal therapy in acne.
Thiboutot D; Chen W
Dermatology; 2003; 206(1):57-67. PubMed ID: 12566806
[TBL] [Abstract][Full Text] [Related]
8. Advances in the treatment of acne.
Kimball AB
J Reprod Med; 2008 Sep; 53(9 Suppl):742-52. PubMed ID: 18980046
[TBL] [Abstract][Full Text] [Related]
9. The effect of 2 combined oral Contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea.
van Vloten WA; van Haselen CW; van Zuuren EJ; Gerlinger C; Heithecker R
Cutis; 2002 Apr; 69(4 Suppl):2-15. PubMed ID: 12096825
[TBL] [Abstract][Full Text] [Related]
10. Treatment of moderate acne vulgaris using a combined oral contraceptive containing ethinylestradiol 20 μg plus drospirenone 3mg administered in a 24/4 regimen: a pooled analysis.
Koltun W; Maloney JM; Marr J; Kunz M
Eur J Obstet Gynecol Reprod Biol; 2011 Apr; 155(2):171-5. PubMed ID: 21288628
[TBL] [Abstract][Full Text] [Related]
11. Treatment of acne using a 3-milligram drospirenone/20-microgram ethinyl estradiol oral contraceptive administered in a 24/4 regimen: a randomized controlled trial.
Maloney JM; Dietze P; Watson D; Niknian M; Lee-Rugh S; Sampson-Landers C; Korner P
Obstet Gynecol; 2008 Oct; 112(4):773-81. PubMed ID: 18827119
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerance of acne treatment using both spironolactone and a combined contraceptive containing drospirenone.
Krunic A; Ciurea A; Scheman A
J Am Acad Dermatol; 2008 Jan; 58(1):60-2. PubMed ID: 17964689
[TBL] [Abstract][Full Text] [Related]
13. Oral contraceptives as anti-androgenic treatment of acne.
Lemay A; Poulin Y
J Obstet Gynaecol Can; 2002 Jul; 24(7):559-67. PubMed ID: 12196847
[TBL] [Abstract][Full Text] [Related]
14. Pharmacology of hormonal contraceptives and acne.
O'Connell K; Westhoff C
Cutis; 2008 Jan; 81(1 Suppl):8-12. PubMed ID: 18338652
[TBL] [Abstract][Full Text] [Related]
15. A combined oral contraceptive containing 3-mg drospirenone/ 20-microg ethinyl estradiol in the treatment of acne vulgaris: a randomized, double-blind, placebo-controlled study evaluating lesion counts and participant self-assessment.
Lucky AW; Koltun W; Thiboutot D; Niknian M; Sampson-Landers C; Korner P; Marr J
Cutis; 2008 Aug; 82(2):143-50. PubMed ID: 18792547
[TBL] [Abstract][Full Text] [Related]
16. A single-center, randomized double-blind, parallel-group study to examine the safety and efficacy of 3mg drospirenone/0.02 mg ethinyl estradiol compared with placebo in the treatment of moderate truncal acne vulgaris.
Palli MB; Reyes-Habito CM; Lima XT; Kimball AB
J Drugs Dermatol; 2013 Jun; 12(6):633-7. PubMed ID: 23839178
[TBL] [Abstract][Full Text] [Related]
17. A randomized controlled trial of a low-dose combined oral contraceptive containing 3 mg drospirenone plus 20 microg ethinylestradiol in the treatment of acne vulgaris: lesion counts, investigator ratings and subject self-assessment.
Maloney JM; Dietze P; Watson D; Niknian M; Lee-Rugh S; Sampson-Landers C; Korner P
J Drugs Dermatol; 2009 Sep; 8(9):837-44. PubMed ID: 19746676
[TBL] [Abstract][Full Text] [Related]
18. [Jangee – young, free and beautiful].
Velev P
Akush Ginekol (Sofiia); 2012; 51 Suppl 1():47. PubMed ID: 23236681
[No Abstract] [Full Text] [Related]
19. The use of low dose oral contraceptives for the management of acne.
Lemay A; Langley RG
Skin Therapy Lett; 2002 Dec; 7(10):1-5. PubMed ID: 12658330
[TBL] [Abstract][Full Text] [Related]
20. [Cutaneous effects in hormonal contraception].
Thomas P; Dalle E; Revillon B; Delecour M; Devarenne-nicolle MF; Pagniez I
NPN Med; 1985 Jan; 5(81):19-24. PubMed ID: 12281276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
